Oncogene - Table of Contents alert Volume 36 Issue 28

If you are unable to see the message below, click here to view.

Advertisement Perfect products for your Cas9 gene editing studies Diagenode's CRISPR/Cas9 collection Cas9 Nuclease protein NLS Largest collection of Cas9 and Cpf1 antibodies from S. pyogenes and S. aureus Validated Cas9 antibodies for ChIP, IP, WB, IF, and more Learn more  TABLE OF CONTENTS Volume 36, Issue 28 (July 2017) In this issue Reviews Original Articles Short Communication Corrigenda Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Celebrating 30 years of Oncogene — 1987 to 2017 Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone.  Watch our anniversary video showing a brief impact overview >>>   Reviews Top Census and evaluation of p53 target genes OPEN M Fischer Oncogene 2017 36: 3943-3956; advance online publication, March 13, 2017; 10.1038/onc.2016.502 Abstract | Full Text FOXC1: an emerging marker and therapeutic target for cancer B Han, N Bhowmick, Y Qu, S Chung, A E Giuliano and X Cui Oncogene 2017 36: 3957-3963; advance online publication, March 13, 2017; 10.1038/onc.2017.48 Abstract | Full Text Original Articles Top Targeting Lyn regulates Snail family shuttling and inhibits metastasis D Thaper, S Vahid, K M Nip, I Moskalev, X Shan, S Frees, M E Roberts, K Ketola, K W Harder, C Gregory-Evans, J L Bishop and A Zoubeidi Oncogene 2017 36: 3964-3975; advance online publication, March 13, 2017; 10.1038/onc.2017.5 Abstract | Full Text MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway L Deng, J Tang, H Yang, C Cheng, S Lu, R Jiang and B Sun Oncogene 2017 36: 3976-3985; advance online publication, March 13, 2017; 10.1038/onc.2016.491 Abstract | Full Text MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF OPEN B Li, W W Xu, L Han, K T Chan, S W Tsao, N P Y Lee, S Law, L Y Xu, E M Li, K W Chan, Y R Qin, X Y Guan, Q Y He and A L M Cheung Oncogene 2017 36: 3986-4000; advance online publication, March 13, 2017; 10.1038/onc.2017.29 Abstract | Full Text Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling OPEN D J Junk, B L Bryson, J M Smigiel, N Parameswaran, C A Bartel and M W Jackson Oncogene 2017 36: 4001-4013; advance online publication, March 13, 2017; 10.1038/onc.2017.33 Abstract | Full Text Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression OPEN R Gupta, Q Yang, S K Dogra and N Wajapeyee Oncogene 2017 36: 4014-4024; advance online publication, March 13, 2017; 10.1038/onc.2017.37 Abstract | Full Text Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome OPEN G V Walls, M Stevenson, K E Lines, P J Newey, A A C Reed, M R Bowl, J Jeyabalan, B Harding, K J Bradley, S Manek, J Chen, P Wang, B O Williams, B T Teh and R V Thakker Oncogene 2017 36: 4025-4036; advance online publication, March 13, 2017; 10.1038/onc.2017.43 Abstract | Full Text MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer A Bouillez, H Rajabi, C Jin, M Samur, A Tagde, M Alam, M Hiraki, T Maeda, X Hu, D Adeegbe, S Kharbanda, K-K Wong and D Kufe Oncogene 2017 36: 4037-4046; advance online publication, March 13, 2017; 10.1038/onc.2017.47 Abstract | Full Text CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis X Hu, Y Zhao, L Wei, B Zhu, D Song, J Wang, L Yu and J Wu Oncogene 2017 36: 4047-4059; advance online publication, March 20, 2017; 10.1038/onc.2017.10 Abstract | Full Text CAMK2γ in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation X Ma, Z Meng, L Jin, Z Xiao, X Wang, W M Tsark, L Ding, Y Gu, J Zhang, B Kim, M He, X Gan, J E Shively, H Yu, R Xu and W Huang Oncogene 2017 36: 4060-4071; advance online publication, March 20, 2017; 10.1038/onc.2017.16 Abstract | Full Text FOXA1 inhibits prostate cancer neuroendocrine differentiation J Kim, H Jin, J C Zhao, Y A Yang, Y Li, X Yang, X Dong and J Yu Oncogene 2017 36: 4072-4080; advance online publication, March 20, 2017; 10.1038/onc.2017.50 Abstract | Full Text Short Communication Top CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner OPEN L Huang, Z Wang, C Liu, C Xu, R M Mbofung, J A McKenzie, H Khong, P Hwu and W Peng Oncogene 2017 36: 4081-4086; advance online publication, March 6, 2017; 10.1038/onc.2017.35 Abstract | Full Text Corrigenda Top Manganese superoxide dismutase deficiency triggers mitochondrial uncoupling and the Warburg effect Y Xu, S Miriyala, F Fang, V Bakthavatchalu, T Noel, D M Schnell, C Wang, W H St Clair and D K St Clair Oncogene 2017 36: 4087; advance online publication, March 13, 2017; 10.1038/onc.2016.513 Full Text Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition OPEN Q Zhang, T Wei, K Shim, K Wright, K Xu, H L Palka-Hamblin, A Jurkevich and S Khare Oncogene 2017 36: 4088; advance online publication, March 13, 2017; 10.1038/onc.2017.56 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.